Eye Infections, Viral: Clinical Trials

94 trials for Eye Infections, Viral, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

76 completed, 8 unknown, 4 withdrawn, 3 recruiting. 32 Not applicable, 16 Phase 2, 15 Phase 3, 10 Phase 1, 6 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable32Completed 24, Unknown 4, Withdrawn 2, Recruiting 1, Terminated 1
Phase 216Completed 14, Recruiting 1, Withdrawn 1
Phase 315Completed 13, Unknown 2
Phase 110Completed 7, Active not recruiting 1, Recruiting 1, Withdrawn 1
Phase 46Completed 5, Terminated 1
Early Phase 11Recruiting 1

Follow Eye Infections, Viral: new trials by email Literature Review of Eye Infections, Viral trials Research Report on Eye Infections, Viral

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Safety and Efficacy of Autologous LB-DTK-CMV in Patients With Antiviral-Resistant and Refractory Cytomegalovirus Retinitis.
LB-DTK-CMV - CMV Retinitis
Not applicableRecruitingLucasBio52026-04-272026-07-01
Clinical Study of Intrastromal Anti-VEGF Injection for Corneal Neovascularization.
Intrastromal anti-VEGF injection and topical antiviral eye drops, Conventional antiviral topical ocular drops. - Herpes Simplex Keratitis, Corneal Neovascularization
Phase 1 / Phase 2RecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine1002025-10-012026-01-09
Topical Ganciclovir Versus Systemic Aciclovir in the Treatment of Herpetic Keratitis
Acyclovir 400 MG, Ganciclovir (GCV) - Herpetic Keratitis
Not applicableCompletedAl-Azhar University202024-10-012025-01-03
A Study of the Safety, Tolerability and Prelinminary Efficacy of BD111 in Herpes Simplex Virus Type I Stromal Keratitis
BD111 Injection (Investigative New Drug), Triple-drugs therapy of HSV-1 stromal keratitis - Herpes Simplex Virus Type I Stromal Keratitis
Phase 1Active not recruitingShanghai BDgene Co., Ltd.162023-09-042025-05-18
Clinical Study of High Concentration Ganciclovir Eye Drops in the Treatment of Cytomegalovirus Retinitis
2% Ganciclovir Eye Drops - Cytomegalovirus Retinitis, Ganciclovir Eye Drops
Early Phase 1RecruitingTianjin Medical University152023-07-012023-06-23
Can COVID-19 Persist in Intraocular Fluid?
routine care intraocular sx - Ocular Infection, Viral
CompletedVanderbilt University Medical Center252021-06-162024-09-23
Deep Learning-based System and AIDS-related Cytomegalovirus Retinitis
Cytomegalovirus Retinitis
CompletedKuifang Du502021-04-012021-07-21
Evaluating Adjunctive Cryopreserved Amniotic Membrane Treatment in Herpes Simplex Dendritic Keratitis
Prokera Slim, Standard of Care - Herpes Simplex Dendritic Keratitis
Not applicableWithdrawnOregon Health and Science University2021-01-212022-09-22
Defining the Operating Parameters for a Rebound-esthesiometer
Esthesiometer measurement - Corneal Sensation Reduced, Corneal Dystrophy
UnknownIcare Finland Oy1002020-08-012020-07-29
Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic
Conjunctivitis, SARS-CoV-2
CompletedJohns Hopkins University362020-05-182024-05-31
The Effect Of Preoperative Parameters On Success After DMEK Surgery
Descemet membrane endothelial keratoplasty (DMEK) - Fuchs' Endothelial Dystrophy, Pseudophakic Bullous Keratopathy
CompletedBeyoglu Eye Research and Education Hospital432019-06-012022-07-20
Viral Conjunctivitis Treatment Study
0.01% Hypochlorous acid, Placebo - Viral Conjunctivitis
Not applicableTerminatedUniversity of Miami112018-11-142021-12-29
Zoster Eye Disease Study
Masked Placebo, Masked Oral Valacyclovir - Herpes Zoster Ophthalmicus
Phase 4CompletedNYU Langone Health5272017-08-232025-03-07
Femtosecond Laser-assisted Corneal Debridement for Herpes Simplex Keratitis
FLDEB, Ganciclovir (GCV), Femtosecond laser - Herpes Simplex Keratitis
Not applicableUnknownChunxiao Wang1002017-07-202018-02-22
Implantable Intraocular Pressure Sensor for Glaucoma Monitoring in Patients With Boston Keratoprosthesis Type 1
EyeMate - Glaucoma, Blindness, Acquired
Not applicableWithdrawnCentre hospitalier de l'Université de Montréal (CHUM)2016-11-012018-02-05
Observation on the Herpes Simplex Keratitis
Pranoprofen - Keratitis, Herpetic
UnknownPeking Union Medical College1002016-11-012017-01-09
Topical Anesthesia for Closed PKP vs Retrobulbar Anesthesia for Open-sky PKP
closed PKP under topical anesthesia, open-sky PKP under retrobulbar anesthesia, Anti-Rejection Agents - Corneal Opacity, Keratitis, Herpetic
Not applicableUnknownWenzhou Medical University602015-12-012016-07-07
ADenoVirus Initiative Study in Epidemiology in UK
Viral Conjunctivitis
CompletedNicOx312015-02-012015-10-20
ADenoVirus Initiative Study in Epidemiology in Italy
Viral Conjunctivitis
CompletedNicOx2412014-11-012017-02-16
ADenoVirus Initiative Study in Epidemiology in Spain
Viral Conjunctivitis
CompletedNicOx3862014-07-012017-01-10

Showing 20 of 94. Sign in to see all of them.

Narrower conditions

Cytomegalovirus Retinitis (64)  ·  HIV Infections (57)  ·  Acquired Immunodeficiency Syndrome (46)  ·  Retinitis (36)  ·  Cytomegalovirus Infections (32)  ·  Multiple Acyl Coenzyme A Dehydrogenase Deficiency (32)  ·  AIDS-Related Opportunistic Infections (25)  ·  Conjunctivitis, Viral (14)  ·  Keratitis, Herpetic (13)  ·  Conjunctivitis (4)  ·  Adenoviridae Infections (2)  ·  Corneal Diseases (2)  ·  Corneal Dystrophies, Hereditary (2)  ·  Corneal Opacity (2)

Broader conditions

Eye Diseases (94)  ·  Virus Diseases (94)  ·  Eye Infections (93)  ·  Infections (93)  ·  DNA Virus Infections (80)  ·  Herpesviridae Infections (79)  ·  Retinal Diseases (63)  ·  RNA Virus Infections (62)  ·  Urogenital Diseases (62)  ·  Genital Diseases (61)  ·  Immune System Diseases (61)  ·  Blood-Borne Infections (60)  ·  Communicable Diseases (60)  ·  Immunologic Deficiency Syndromes (60)

Interventions

Ganciclovir (30)  ·  Foscarnet (13)  ·  Cidofovir (10)  ·  Probenecid (5)  ·  Acyclovir (4)  ·  fomivirsen (4)  ·  sevirumab (4)  ·  Valganciclovir (3)  ·  Zidovudine (3)  ·  Lubricant Eye Drops (2)  ·  Valacyclovir (2)  ·  sargramostim (2)  ·  Alfentanil (1)  ·  Amikacin (1)  ·  Aminocaproic Acid (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (21)  ·  Hoffmann-La Roche (9)  ·  Johns Hopkins Bloomberg School of Public Health (6)  ·  National Eye Institute (NEI) (5)  ·  NicOx (5)  ·  Astra USA (4)  ·  Ionis Pharmaceuticals, Inc. (4)  ·  Gilead Sciences (3)  ·  Roche Global Development (3)  ·  Rapid Pathogen Screening (2)  ·  Adenovir Pharma AB (1)  ·  Agouron Pharmaceuticals (1)  ·  Al-Azhar University (1)  ·  American National Red Cross (1)  ·  Beyoglu Eye Research and Education Hospital (1)

Countries

United States (59)  ·  Canada (8)  ·  China (7)  ·  United Kingdom (4)  ·  Brazil (3)  ·  Germany (3)  ·  Austria (1)  ·  Egypt (1)  ·  France (1)  ·  Israel (1)  ·  Italy (1)  ·  Poland (1)  ·  Puerto Rico (1)  ·  Singapore (1)  ·  South Korea (1)

Top investigators

Douglas Jabs, MD (2)  ·  Hardy WD (2)  ·  MA Jacobson (2)  ·  Shachar Tauber, MD (2)  ·  Adisak Trinavarat, MD (1)  ·  Borucki M (1)  ·  Brosgart C (1)  ·  C Crumpacker (1)  ·  CA Benson (1)  ·  CS Crumpacker (1)  ·  Carl Gustaf Laurell, MD PhD (1)  ·  Chao Chen (1)  ·  Chi Hornik, PharmD (1)  ·  Chris Starr, MD (1)

Results publications

PMID 31042791, PMID 11919489, PMID 12232843, PMID 12559647, PMID 15498605, PMID 16192248, PMID 18677274, PMID 21320979, PMID 22331114, PMID 23307204, PMID 24614374, PMID 24949994, PMID 26039810, PMID 26926644, PMID 27522443, PMID 28137820, PMID 28290120, PMID 28779462, PMID 29084742, PMID 29271816, PMID 29435949, PMID 29677389, PMID 30790601, PMID 31317556, PMID 31548185, PMID 31814149, PMID 32324313, PMID 32497307, PMID 33029806, PMID 33903114, PMID 34302290, PMID 35090154, PMID 35370711, PMID 35491971, PMID 35810243, PMID 38411973, PMID 40048183, PMID 40048191, PMID 41247430, PMID 42593809, PMID 42635062, PMID 9400786

NIH funding

U10EY008057 (3), U01AI027668 (1), U10EY026869 (1)